Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
235 hedge funds and large institutions have $3.3B invested in Axonics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 93 increasing their positions, 72 reducing their positions, and 34 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 72
9% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 34
1% more capital invested
Capital invested by funds: $3.26B → $3.3B (+$39.2M)
0% more funds holding
Funds holding: 235 → 235 (0)
0% more funds holding in top 10
Funds holding in top 10: 18 → 18 (0)
39% less call options, than puts
Call options by funds: $7.44M | Put options by funds: $12.1M
Top Buyers
| 1 |
SFM
Soros Fund Management
New York
|
+$99.6M |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
+$70.6M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$67.8M |
| 4 |
AGDI
Absolute Gestao de Investimentos
Sao Paulo,
Brazil
|
+$32.7M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$23.7M |
Top Sellers
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$61.7M |
| 2 |
BAMCO Inc
New York
|
-$47.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$46.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$45.2M |
| 5 |
Amundi
Paris,
France
|
-$34.7M |
AXNX Hedge Fund Activity: Q2 2024 in Review
235 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2024, worth a combined $3.3B — up 1.2% from $3.26B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new AXNX positions and 34 closed out — a net gain of 3 holders — while 93 added to existing stakes and 72 trimmed.
The largest buyer was Soros Fund Management, adding an estimated $99.6M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $61.7M sold.
- 235 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $3.3B of Axonics, Inc. Common Stock stock for Q2 2024, up 1.2% quarter-over-quarter.
- 37 funds opened new Axonics, Inc. Common Stock positions in Q2 2024 and 34 closed out, a net change of +3 holders.
- The largest Axonics, Inc. Common Stock buyer in Q2 2024 was Soros Fund Management, an estimated $99.6M added.
- The largest Axonics, Inc. Common Stock seller in Q2 2024 was Champlain Investment Partners, an estimated $61.7M sold.
Based on aggregated 13F filings for Q2 2024.